“…The two non-randomised control trials each had two study arms. 49,60 Study populations included adults with cardiovascular disease (CVD) (n = 16 studies), 25,27,[29][30][31]33,35,37,39,40,43,48,50,53,60,62 Type 2 DM (n = 13 studies), 26,32,41,42,44,45,52,55,58,59,61,63 unspecified DM (n = 1 study), 38 obesity (n = 4 studies), 46,49,56,57 CKD (n = 3 studies) 28,51,54 and combined population group (n = 2). 34,47 The duration of the studies ranged from eight weeks to 24 months.…”